Annemiek Broyl
Erasmus MC(NL)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial(2012)821 cited
- → Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib(2006)418 cited
- → Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients(2010)336 cited
- → A gene expression signature for high-risk multiple myeloma(2012)300 cited
- → Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial(2010)220 cited
- → Genome-wide association study identifies multiple susceptibility loci for multiple myeloma(2016)177 cited
- → High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance(2012)128 cited
- → Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma(2018)113 cited
- → Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy(2011)71 cited
- → Gene expression profile alone is inadequate in predicting complete response in multiple myeloma(2014)64 cited